Finance Watch: US, Hong Kong IPOs Are Hot, But Sirnaomics Stays Private
The US- And China-Based Firm Raised A $105m Series E Round
Private Company Edition: Sirnaomics planned to go public after its series D, but its new venture capital does not prevent it from doing so in the near term. Also, Vida Ventures and Novalis Biotech raised new VC funds to back start-ups and ArriVent launched with up to $150m in series A cash.
